MarketingRx roundup: Bluebird bio promotes sickle cell awareness; Pfizer, BioNTech encourage boosters in South
While bluebird bio is expected to file an application with the FDA for its sickle cell disease (SCD) drug candidate in the first quarter, it’s already raising awareness online. Two websites — one for healthcare providers called “Change for SCD” and another for patients and caregivers called “Spark Sickle Cell Change” — feature real physicians and patients talking about sickle cell disease stigma and other issues.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.